The groundbreaking approach of this peptide represents a major development in the management of type 2 diabetes. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide181224.canariblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56972903